Mithra
Jean-Manuel Fontaine has a diverse work experience spanning multiple industries. Jean-Manuel began their career in 1996 at Pfizer, where they held various roles in sales, production planning, project management, and manufacturing. In 2001, they joined Lundbeck as a District Manager and later became a Group Product Manager, contributing to the development of franchise and product strategies. From 2010 to 2013, Jean-Manuel worked at UCB Pharma as an Associate Director in Global Marketing, focusing on strategic alignment, market access, and customer engagement. In 2013, they joined Mithra Pharmaceuticals, initially serving as the Head of Business Development and later taking on roles in public affairs and scientific affairs. Currently, Jean-Manuel holds the position of Chief Business Officer at Mithra Pharmaceuticals SA.
Jean-Manuel Fontaine obtained a Master of Business Administration (MBA) in Business Administration and Management from Cornell Johnson Graduate School of Management in 1996. Prior to this, they earned a Master's degree in Pharmaceutical Sciences from Université catholique de Louvain between 1989 and 1994. There is no available information regarding their education before attending lycée francais de jérusalem.
Mithra
Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra also develops and manufactures complex therapeutics in the areas of contraception, menopause and hormone-dependent cancers. It offers partners a complete spectrum of research, development and specialist manufacturing at its technological platform Mithra CDMO. Active in more than 100 countries around the world, Mithra has an approximate headcount of 300 staff members and is headquartered in Liège, Belgium. www.mithra.com